• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响胰腺导管腺癌手术切除后长期生存的因素。

Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma.

作者信息

Yoon Kyoung Won, Heo Jin Seok, Choi Dong Wook, Choi Seoung Ho

机构信息

Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

J Korean Surg Soc. 2011 Dec;81(6):394-401. doi: 10.4174/jkss.2011.81.6.394. Epub 2011 Nov 25.

DOI:10.4174/jkss.2011.81.6.394
PMID:22200040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3243856/
Abstract

PURPOSE

Some patients who undergo surgical resection of pancreatic cancer survive longer than other patients. The purpose of this study was to identify the factors that affect long-term survival after resection of histopathologically confirmed pancreatic ductal adenocarcinoma.

METHODS

A single-center, retrospective study was conducted among 164 patients who underwent surgical resection of pancreatic cancer, between May 1995 and December 2004. The patient follow-up process was conducted via telephone survey and review of electronic medical records for at least 5 years or until death.

RESULTS

We compared patients with long-term (≥60 months, n = 19) and short-term survival (<60 months, n = 145). Resection margin status, differentiation of the tumor, tumor stage, pre-operative serum level of albumin, total bilirubin and carbohydrate antigen (CA) 19-9 level are related with survival difference (all factors, P < 0.05). Multivariate analysis revealed that a pre-operative serum total bilirubin level <7 mg/dL and a pre-operative serum CA19-9 level <37 U/mL is a statistically significant prognostic factor for long-term survival.

CONCLUSION

The preoperative serum total bilirubin and serum CA19-9 levels are associated with long-term survival after surgical resection of pancreatic cancer.

摘要

目的

一些接受胰腺癌手术切除的患者比其他患者存活时间更长。本研究的目的是确定影响经组织病理学确诊的胰腺导管腺癌切除术后长期生存的因素。

方法

对1995年5月至2004年12月期间164例行胰腺癌手术切除的患者进行单中心回顾性研究。通过电话调查和查阅电子病历对患者进行至少5年的随访或直至死亡。

结果

我们比较了长期生存(≥60个月,n = 19)和短期生存(<60个月,n = 145)的患者。切缘状态、肿瘤分化程度、肿瘤分期、术前血清白蛋白水平、总胆红素水平和糖类抗原(CA)19-9水平与生存差异相关(所有因素,P < 0.05)。多因素分析显示,术前血清总胆红素水平<7 mg/dL和术前血清CA19-9水平<37 U/mL是长期生存的统计学显著预后因素。

结论

术前血清总胆红素和血清CA19-9水平与胰腺癌手术切除后的长期生存相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aec/3243856/b1e755709b55/jkss-81-394-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aec/3243856/b1e755709b55/jkss-81-394-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aec/3243856/b1e755709b55/jkss-81-394-g001.jpg

相似文献

1
Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma.影响胰腺导管腺癌手术切除后长期生存的因素。
J Korean Surg Soc. 2011 Dec;81(6):394-401. doi: 10.4174/jkss.2011.81.6.394. Epub 2011 Nov 25.
2
Comparison of the prognostic impact of pre- and post-operative CA19-9, SPan-1, and DUPAN-II levels in patients with pancreatic carcinoma.胰腺癌患者术前和术后CA19-9、SPan-1及DUPAN-II水平对预后影响的比较
Pancreatology. 2017 Jan-Feb;17(1):95-102. doi: 10.1016/j.pan.2016.10.004. Epub 2016 Oct 11.
3
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.围手术期CA19-9水平可预测可切除胰腺腺癌患者的分期及生存情况。
J Clin Oncol. 2006 Jun 20;24(18):2897-902. doi: 10.1200/JCO.2005.05.3934.
4
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.术前 CEA 和 CA 19-9 是可切除性胰腺导管腺癌患者生存的预后标志物——一项回顾性肿瘤标志物预后研究。
Int J Surg. 2013;11(10):1067-72. doi: 10.1016/j.ijsu.2013.10.005. Epub 2013 Oct 23.
5
Preoperative CA19-9 levels and lymph node ratio are independent predictors of survival in patients with resected pancreatic ductal adenocarcinoma.术前CA19-9水平和淋巴结比率是接受手术切除的胰腺导管腺癌患者生存的独立预测因素。
Dig Surg. 2008;25(3):226-32. doi: 10.1159/000140961. Epub 2008 Jun 24.
6
Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.术后血清癌胚抗原(CEA)和糖类抗原125(CA125)水平在预测胰腺导管腺癌手术结果方面对围手术期糖类抗原19-9(CA19-9)水平具有补充作用。
Surgery. 2017 Feb;161(2):373-384. doi: 10.1016/j.surg.2016.08.005. Epub 2016 Nov 9.
7
Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.胰腺癌切除术后的长期生存:一项单中心回顾性分析。
World J Gastroenterol. 2015 Jan 7;21(1):262-8. doi: 10.3748/wjg.v21.i1.262.
8
Preoperative serum CA19-9 and dissected peripancreatic tissue margin as determiners of long-term survival in pancreatic cancer.术前血清CA19-9及胰腺周围组织切缘作为胰腺癌长期生存的决定因素
Ann Surg Oncol. 2009 May;16(5):1231-40. doi: 10.1245/s10434-009-0415-7. Epub 2009 Mar 5.
9
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?胰腺癌胰十二指肠切除术后的长期生存:能否治愈?
Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.
10
CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy.CA19-9 在可切除胰腺癌中的应用:调整手术和围手术期治疗的视角。
Ann Surg Oncol. 2013 Jul;20(7):2188-96. doi: 10.1245/s10434-012-2809-1. Epub 2012 Dec 18.

引用本文的文献

1
Predictors for Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.胰腺导管腺癌切除术后长期生存的预测因素:一项系统评价和荟萃分析。
Ann Surg Oncol. 2024 Jul;31(7):4673-4687. doi: 10.1245/s10434-024-15281-1. Epub 2024 May 6.
2
Preoperative Biliary Drainage Does Not Independently Reduce Survival After Pancreaticoduodenectomy Among Patients With Pancreatic Ductal Adenocarcinoma: A National Registry Study.术前胆道引流并不能独立降低胰腺导管腺癌患者胰十二指肠切除术后的生存率:一项全国性登记研究。
Ann Surg Open. 2021 Aug 13;2(3):e090. doi: 10.1097/AS9.0000000000000090. eCollection 2021 Sep.
3

本文引用的文献

1
Pancreatic cancer: epidemiology and risk factors.胰腺癌:流行病学和危险因素。
Dig Dis. 2010;28(2):355-8. doi: 10.1159/000319414. Epub 2010 Sep 1.
2
Cancer statistics in Korea: incidence, mortality and survival in 2006-2007.韩国癌症统计数据:2006-2007 年的发病率、死亡率和生存率。
J Korean Med Sci. 2010 Aug;25(8):1113-21. doi: 10.3346/jkms.2010.25.8.1113. Epub 2010 Jul 21.
3
Pancreatic cancer and pancreaticoduodenectomy in elderly patient: morbidity and mortality are increased. Is it the real life?老年患者的胰腺癌与胰十二指肠切除术:发病率和死亡率均升高。这是现实情况吗?
Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.
胰十二指肠切除术后胰头导管腺癌患者的预后列线图
Clin Med Insights Oncol. 2021 Jun 18;15:11795549211024149. doi: 10.1177/11795549211024149. eCollection 2021.
4
Achieving 'Marginal Gains' to Optimise Outcomes in Resectable Pancreatic Cancer.实现“微小进步”以优化可切除胰腺癌的治疗效果
Cancers (Basel). 2021 Apr 1;13(7):1669. doi: 10.3390/cancers13071669.
5
Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China.胰腺癌的临床病理特征、实验室参数、治疗方案及预后:一项针对中国1433例患者的回顾性队列研究
PeerJ. 2018 May 28;6:e4893. doi: 10.7717/peerj.4893. eCollection 2018.
6
Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.可切除性胰腺腺癌患者的生存及预后因素分析
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):612-620. doi: 10.1007/s11596-017-1780-2. Epub 2017 Aug 8.
7
Does Hyperbilirubinemia Contribute to Adverse Patient Outcomes Following Pancreatoduodenectomy?高胆红素血症是否会导致胰十二指肠切除术后患者出现不良预后?
J Gastrointest Surg. 2017 Apr;21(4):647-656. doi: 10.1007/s11605-017-3381-6. Epub 2017 Feb 15.
8
Factors affecting survival in patients who underwent pancreaticoduodenectomy for periampullary cancers.影响壶腹周围癌患者行胰十二指肠切除术后生存的因素。
Ulus Cerrahi Derg. 2015 Jun 1;31(2):72-7. doi: 10.5152/UCD.2015.2674. eCollection 2015.
9
Expression of astrocyte elevated gene-1 (AEG-1) as a biomarker for aggressive pancreatic ductal adenocarcinoma.星形胶质细胞上调基因-1(AEG-1)的表达作为侵袭性胰腺导管腺癌的生物标志物
BMC Cancer. 2014 Jul 3;14:479. doi: 10.1186/1471-2407-14-479.
10
Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas.黄疸:一种重要但未被充分认识的风险因素,可降低头颈部胰腺腺癌患者的生存。
HPB (Oxford). 2014 Feb;16(2):150-6. doi: 10.1111/hpb.12094. Epub 2013 Apr 22.
Hepatogastroenterology. 2008 Nov-Dec;55(88):2242-6.
4
The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.手术切除后中、远端胆管癌的生存结局及预后因素
J Surg Oncol. 2009 May 1;99(6):335-42. doi: 10.1002/jso.21238.
5
Prognostic factors after resection of pancreatic cancer.胰腺癌切除术后的预后因素。
World J Surg. 2009 Jan;33(1):104-10. doi: 10.1007/s00268-008-9807-2.
6
Preoperative resolution of jaundice following biliary stenting predicts more favourable early survival in resected pancreatic ductal adenocarcinoma.胆管支架置入术后黄疸的术前消退预示着切除的胰腺导管腺癌患者早期生存率更高。
Ann Surg Oncol. 2008 Nov;15(11):3138-46. doi: 10.1245/s10434-008-0148-z. Epub 2008 Sep 12.
7
Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?胰腺癌胰十二指肠切除术后的长期生存:能否治愈?
Ann Surg. 2008 Mar;247(3):456-62. doi: 10.1097/SLA.0b013e3181613142.
8
Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma.对可能可切除的胰腺腺癌患者进行探查时可切除性的替代标志物。
J Gastrointest Surg. 2008 Jun;12(6):1068-73. doi: 10.1007/s11605-007-0422-6. Epub 2007 Nov 28.
9
Postoperative adjuvant chemotherapy improves survival after surgical resection for pancreatic carcinoma.术后辅助化疗可提高胰腺癌手术切除后的生存率。
J Gastrointest Surg. 2008 Mar;12(3):534-41. doi: 10.1007/s11605-007-0407-5. Epub 2007 Nov 17.
10
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.1423例胰腺癌胰十二指肠切除术:单中心经验
J Gastrointest Surg. 2006 Nov;10(9):1199-210; discussion 1210-1. doi: 10.1016/j.gassur.2006.08.018.